Creating a fully implanted heart pump to help patients with heart failure
Development of a Totally Implanted Left Ventricular Assist Device
['FUNDING_SBIR_2'] · CORVION, INC. · NIH-11067361
This study is testing a new heart pump that goes inside your body to help people with heart failure, making it safer and easier to live with than current options, so you can feel better while waiting for a heart transplant or recovering.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CORVION, INC. (nih funded) |
| Locations | 1 site (WEBSTER, UNITED STATES) |
| Trial ID | NIH-11067361 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a Totally Implanted Left Ventricular Assist Device (TI-LVAD) for patients suffering from heart failure. The device aims to reduce complications associated with current heart pumps, such as infections and quality of life issues, by eliminating the need for external components. By utilizing an ultra-low-power blood pump and an implantable battery with wireless charging, the TI-LVAD seeks to improve patient outcomes and encourage more individuals to consider this life-saving option. The goal is to provide a reliable alternative for patients who may be waiting for a heart transplant or seeking recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with heart failure who may benefit from a left ventricular assist device.
Not a fit: Patients with mild heart failure or those who are not candidates for mechanical support may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for heart failure patients by reducing complications and making heart pump technology more accessible.
How similar studies have performed: Previous research has shown promise in developing advanced heart pump technologies, but this approach with a fully implanted device is relatively novel.
Where this research is happening
WEBSTER, UNITED STATES
- CORVION, INC. — WEBSTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ABER, GREG — CORVION, INC.
- Study coordinator: ABER, GREG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.